EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients
Recruitment status was Recruiting
Continuous measurement of breathing patterns, heart rate, restlessness and cough in sleep using EarlySense ES 16 device. Predicting worsening in COPD patients' condition using the above parameters.
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||EarlySense Monitoring Device Evaluation on Patients in Med / Surg|
|Study Start Date:||January 2008|
|Estimated Primary Completion Date:||February 2009 (Final data collection date for primary outcome measure)|
Device: Earlysense vital sign monitor
Study's participants are CHF, COPD and Pneumonia patients or patients who are otherwise hospitalized in internal medicine department. During the study the patients' breathing patterns, heart rate, restlessness and cough in sleep will be measured by the EarlySense ES 16 device, which is placed in the patients' bed.
Patients' clinical status are followed. The patient's clinical condition is followed and analyzed in comparison to the EarlySense system output in order to determine the capability of the EarlySense system to predict COPD, CHF or Pneumonia deteriorations.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00361426
|Contact: Avner Halperinemail@example.com|
|Contact: Hadar Rittefirstname.lastname@example.org|
|Chaim Sheba Medical Center||Recruiting|
|Ramat Gan, Israel|
|Contact: Eyal Zimlichman, M.D. email@example.com|
|Principal Investigator: Eyal Zimlichman, MD|
|Principal Investigator:||Martine Szyper-Kravitz, M.D.||Haim Sheba Medical Center, Israel|